BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11812160)

  • 1. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
    Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
    J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
    Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
    Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism.
    Jones WK; Flaherty MP; Tang XL; Takano H; Qiu Y; Banerjee S; Smith T; Bolli R
    J Mol Cell Cardiol; 1999 Aug; 31(8):1469-81. PubMed ID: 10423345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning.
    Cho S; Park EM; Zhou P; Frys K; Ross ME; Iadecola C
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):493-501. PubMed ID: 15689953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart.
    Tejero-Taldo MI; Gursoy E; Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Feb; 34(2):185-95. PubMed ID: 11851358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
    Salloum F; Yin C; Xi L; Kukreja RC
    Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
    Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle.
    Wang WZ; Fang XH; Stepheson LL; Khiabani KT; Zamboni WA
    J Orthop Res; 2004 May; 22(3):578-85. PubMed ID: 15099638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
    Shi EY; Jiang XJ; Bai H; Nakajima Y
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia.
    Maulik N; Tosaki A; Elliott GT; Maulik G; Das DK
    Drugs Exp Clin Res; 1998; 24(3):117-24. PubMed ID: 9825227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
    Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Mar; 34(3):263-77. PubMed ID: 11945020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress.
    Hu A; Jiao X; Gao E; Koch WJ; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
    J Pharmacol Exp Ther; 2006 Aug; 318(2):469-75. PubMed ID: 16574780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive nitric oxide synthase activity is required to trigger ischemic tolerance in mouse retina.
    Zhu Y; Ohlemiller KK; McMahan BK; Park TS; Gidday JM
    Exp Eye Res; 2006 Jan; 82(1):153-63. PubMed ID: 16045907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation.
    Tofukuji M; Metais C; Li J; Hariawala MD; Franklin A; Vassileva C; Li J; Simons M; Sellke FW
    Circulation; 1998 Nov; 98(19 Suppl):II197-204; discussion II204-5. PubMed ID: 9852903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit.
    Wan LL; Xia J; Ye D; Liu J; Chen J; Wang G
    Cardiovasc Ther; 2009; 27(1):28-33. PubMed ID: 19207477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.